Pure Global

Haptoglobin Quantitative Testing Drug - Vietnam Registration 220003543/PCBB-HCM

Access comprehensive regulatory information for Haptoglobin Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loแบกi B medical device is registered under number 220003543/PCBB-HCM and manufactured by Roche Diagnostics GmbH.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Abbott Ireland Diagnostics Division, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
1 Competitors
1 Recent Registrations
220003543/PCBB-HCM
Registration Details
Vietnam MOH Registration: 220003543/PCBB-HCM
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Haptoglobin Quantitative Testing Drug
VN: Thuแป‘c thแปญ xรฉt nghiแป‡m ฤ‘แป‹nh lฦฐแปฃng haptoglobin
Risk Class TTBYT Loแบกi B

Registration Details

220003543/PCBB-HCM

000.00.19.H29-221104-0001

HAPT2

03005593322

Company Information

Technical Details

In vitro testing used to quantify haptoglobin in human serum and plasma on the Roche/Hitachicobasc systems.

Dates and Status

Nov 04, 2022

Companies Making Similar Products
Companies providing products similar to "Haptoglobin Quantitative Testing Drug"